Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up
<p>There is an urgent need to find reliable and accessible blood-based biomarkers for early diagnosis of Parkinson's disease (PD) correlating with clinical symptoms and displaying predictive potential to improve future clinical trials. This led us to a conduct large-scale proteomics appro...
محفوظ في:
| المؤلف الرئيسي: | Ilham Yahya Abdi (17870462) (author) |
|---|---|
| مؤلفون آخرون: | Michael Bartl (11534947) (author), Mohammed Dakna (412368) (author), Houari Abdesselem (14152914) (author), Nour Majbour (3528548) (author), Claudia Trenkwalder (20110) (author), Omar El-Agnaf (2134222) (author), Brit Mollenhauer (482499) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia
حسب: Hanan Ehtewish (17149825)
منشور في: (2023) -
Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
حسب: Hidetomo Murakami (6105284)
منشور في: (2019) -
Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
حسب: Nour Majbour (3528548)
منشور في: (2022) -
Precision biomarker discovery in hypertension through explainable AI and proteomics
حسب: Karthik Sekaran (16845959)
منشور في: (2026) -
Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
حسب: Abu Saleh Md Moin (6189512)
منشور في: (2021)